TRDA

ENTRADA THERAPEUTICS INC

TRDA·29384C108·US·Common Stock·Healthcare - Biotechnology-Activist

TRDA (ENTRADA THERAPEUTICS INC) is held by 80 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($64M), BlackRock, Inc. ($29.8M), VANGUARD CAPITAL MANAGEMENT LLC ($15.9M). Net institutional sentiment: Mixed.

80
Holders
Avg rating(16 Elite)
$211.3M
Total Value
55% (86)
Fund Consensus
42 buying - 34 selling
TRDASmart Money Verdict
View all
Held by 80 funds
16 elite
Who's Trading
InsiderSNSethuraman NatarajanSell $399KMay 4, 2026
InsiderDJDowden Nathan JExercise 15K shMay 4, 2026
InsiderDJDowden Nathan JSell $230KMay 4, 2026
InsiderWJWENTWORTH KORY JAMESSell $32KApr 1, 2026
InsiderDJDowden Nathan JSell $155KMar 10, 2026
InsiderWJWENTWORTH KORY JAMESSell $148KMar 10, 2026
InsiderDJDowden Nathan JSell $41KMar 9, 2026
InsiderWJWENTWORTH KORY JAMESSell $66KMar 9, 2026
ActivistTCTCG Crossover GP I, LLC5.0%Nov 25, 2025
Activist5V5AM Ventures V, L.P.7.8%Nov 18, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
5.1M$64M0.4%-61.25%
0
Increased
2.4M(+9.8%)$29.8M0.0%-57.43%
32
New
1.3M$15.9M0.0%-41.60%
39
Decreased
1M(-0.9%)$13.1M0.0%-47.52%
0
Increased
667,347(+4.3%)$8.4M0.0%-52.44%
29
Increased
533,798(+4.9%)$6.7M0.0%-53.72%
29
Increased
526,043(+60.7%)$6.6M0.0%-46.66%
39
Increased
519,356(+4.3%)$6.6M0.0%+9.85%
28
Decreased
333,914(-8.0%)$4.2M0.0%-41.39%
0
Increased
324,471(+18.7%)$4.1M0.0%-45.10%
31
Increased
234,992(+3.8%)$3M0.0%-56.20%
27
New
220,494$2.8M0.0%-41.60%
36
Increased
215,977(+52.0%)$2.7M0.0%-35.28%
37
Decreased
215,018(-26.6%)$2.7M0.0%+6.18%
0
Decreased
214,751(-3.0%)$2.7M0.0%-52.77%
0
Increased
212,780(+3.7%)$2.7M0.0%-32.57%
27
Decreased
202,084(-20.0%)$2.6M0.0%-29.83%
0
Increased
181,148(+0.1%)$2.3M0.0%+2.82%
26
Decreased
176,126(-32.3%)$2.2M0.0%-14.82%
0
Increased
175,648(+211.3%)$2.2M0.0%-37.74%
42

Showing 1-20 of 86

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used